Abstract: Serum aldosterone levels are often elevated in patients with heart failure and are associated with poor clinical outcomes. Aldosterone can be produced in extra-adrenal tissues including the heart, and the local increase in aldosterone exerts deleterious effects on heart structure and function. Aldosterone has 2 types of effects on intracellular ion milieu and cellular function. One is the classical genomic effect in which aldosterone combines with the intracellular mineralocorticoid receptor, transfers to the nucleus, and stimulates synthesis of various proteins. Another is the non-genomic effect that expresses within minutes without synthesizing proteins. The non-genomic effects of aldosterone are less proved in the heart, but it has been shown that aldosterone rapidly activates Na + influxes via Na + -K + -2Cl -co-transport and Na + /H + exchange, resulting in an increase in intracellular Na + concentration and intracellular alkalinization. These changes in intracellular ion milieu cause positive inotropy, cell swelling, and generation of reactive oxygen species. Thus, the nongenomic effects of aldosterone may contribute, in concert with the genomic effects, to cardiac hypertrophy, fibrosis, and remodeling. This review will discuss the experimental studies examining the mechanisms and physiological/pathophysiological relevance regarding the non-genomic effects of aldosterone in the heart.
INTRODUCTION
The steroid hormone aldosterone is synthesized in the adrenal cortex in response to angiotensin II. The primary effect of aldosterone is to promote renal sodium absorption in exchange for potassium and to maintain electrolyte homeostasis and extra-cellular fluid volume.
Aldosterone levels are often elevated in patients with heart failure and are associated with poor clinical outcomes [1, 2] . The Randomized Aldactone Evaluation Study for congestive heart failure (RALES) has shown that a mineralocorticoid receptor (MR) antagonist, spironolactone, decreases mortality in patients with congestive heart failure [3] . The Eplerenone Post-AMI Heart Failure Efficacy and Survival Study (EPHESUS) has also demonstrated a decreased mortality in patients with left ventricular dysfunction after myocardial infarction treated with an MR-specific antagonist, eplerenone [4] . In both studies, the MR antagonists improved clinical outcomes independently of the effects on blood pressure. The plasma concentration of aldosterone increases up to 0.1 μM in patients with heart failure, and the level of aldosterone in the myocardium is much higher than that in plasma [5, 6] . The rapid and direct effects of aldosterone on the heart are, therefore, considered to have significant clinical relevance and to be important as a therapeutic target for heart failure.
*Address correspondence to this author at the Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine. 1-20-1, Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan; Tel: +81-53-435-2267; Fax: +81-53-434-2910; E-mail: satoh36@hama-med.ac.jp Now it is well known that aldosterone has 2 types of effects on intracellular ion milieu and cellular function. One is the classical genomic effect and the other is the non-genomic effect that expresses within minutes without synthesizing proteins [7, 8] . The non-genomic effect of aldosterone was initially reported at 1964 in dog erythrocytes in which genomic mechanisms did not work because of the lack of nucleus [9] . There are several reports regarding the nongenomic effects of aldosterone in a variety of tissues including vascular endothelium [10] , vascular smooth muscles [11] , kidney cells [12] , skin cells [13] , bronchial epithelium [14] , mononuclear leukocytes [15] , and skeletal muscles [16] . In these tissues, aldosterone rapidly changed intracellular Na [17] [18] [19] . However, there are only a few reports on non-genomic effects of aldosterone, e.g. Na
-co-transporter (NKCCl) and Na + /H + exchange. The aldosterone-induced modulation of these ion transporters can certainly affect intracellular ion regulation and cellular function. However, it is still undefined in cardiac tissues whether aldosterone actually alters intracellular ion concentrations, cell volume or myocardial contractility due to non-genomic effects. This review discusses the non-genomic effects of aldosterone on cellular ion regulation, function, and physiological/patho-physiological implications in cardiac myocytes.
GENOMIC AND NON-GENOMIC EFFECTS OF ALDOSTERONE
Genomic effects of aldosterone imply the binding to its intracellular receptor and the translation of the ligandreceptor-complex to the nucleus, followed by the modulation of transcriptional and translational processes. The receptors that transmit these effects have been cloned and represent the superfamily of steroid receptors, including the classic intracellular MR [13] .
Rapid non-genomic effects of aldosterone have been ascribed to undefined membrane receptors and intracellular signaling pathways. These kinds of aldosterone effects were not blocked by spironolactone, actinomycin D or cycloheximide, suggestive of the distinct mechanisms from the MR, and gene transcription and translation. In vascular smooth muscles and mononuclear leukocytes, aldosterone stimulated phosphoinositide hydrolysis and thus inositol 1,4,5 triphosphate (IP 3 ) and diacylglycerol (DAG) formation within minutes [20] . The increase in IP 3 -induced Ca 2+ release from intracellular Ca 2+ stores could explain the aldosterone-induced increase in [Ca 2+ ] i in these cell types. Aldosterone increased [Ca 2+ ] i and cAMP even in the mice skin cells where MR is knocked out [13] . These effects were not induced by micromolar concentrations of hydrocortisone or blocked by spironolactone. In human bronchial epithelial cells, aldosterone reduced [Ca 2+ ] i via a non-genomic mechanism, involving the activation of endoplasmic reticulum (ER) Ca 2+ -ATPase and adenyl cyclase-and PKA-coupled signaling pathways [14] . In human distal colon and in mouse cortical collecting duct, aldosterone increased [Ca 2+ ] i via protein kinase C (PKC) [21, 22] .
In cardiac myocytes, molecular steps that mediate nongenomic effects of aldosterone remain unclear. Mihailidou et al. reported that aldosterone-induced activation of NKCC1 was mediated by PKC in rabbit ventricular myocytes [23] . Another report by Mano et al. suggested a specific plasma membrane receptor coupled with phospholipase C [24] .
On the other hand, recent reports have indicated that the classical MR seems to participate at least in some rapid nongenomic effects of aldosterone, because MR blockers abolished them [25] . However, we and another study have shown that spironolactone could by itself modify intracellular ion concentrations and cell function independently of MR [26, 27] . Furthermore, under physiological conditions, MRs in cardiac myocytes are normally occupied by endogenous glucocorticoid because 11 -hydroxysteroid dehydrogenase is not usually expressed in cardiac myocytes and there are high levels of circulating cortisol [28] . Thus, at the present state, the specific membrane receptors for aldosterone are not yet cloned, and the involvement of MR remains undefined. Future studies are necessary to elucidate the receptorintracellular signaling pathways of the non-genomic effects of aldosterone. [26, 30] . These aldosterone-induced Na + increases were independent of the MR.
NON-GENOMIC EFFECTS OF ALDOSTERONE
We examined the non-genomic effects of aldosterone on [Na + ] i in isolated rat ventricular myocytes using a laser scanning confocal microscopy and a Na + -sensitive fluorescent dye Sodium-green [27] . Aldosterone rapidly elevated [Na + ] i at the concentrations of 0.1 M to 10 M (Figs. 1A & B) ] i and the concentration of aldosterone varied among the studies (presumably from differences in animal species, specimens and temperature), but the increase was estimated to be 1~1.5 mM [24, [29] [30] [31] .
The non-genomic effects of aldosterone on membrane Na + regulatory proteins have been observed in various cell types. In human mononuclear leukocytes and vascular smooth muscle cells, aldosterone activated Na + /H + exchange, resulting in intracellular alkalinization [15, 32] . In vascular smooth muscle cells, the involvement of NKCC1 in aldosterone-induced changes in Na + flux was also described [11] .
In (Fig. 1D) . These findings were also found in other studies [29, 30] ] i within 1 h in human mononuclear leukocytes, cultured skeletal muscle cells and porcine aortic endothelial cells [16, 35, 36] . In these tissues, the aldosterone-induced increase in [Ca 2+ ] i was thought to be mainly mediated by phosphoinositide hydrolysis. The production of IP 3 caused a Ca 2+ release from intracellular IP 3 -sensitive stores.
In adult cardiac myocytes, this mechanism seems to be rather small since Ca 2+ -induced Ca 2+ release from the sarcoplasmic reticulum is more important for excitationcontraction coupling. Actually, there are no reports that showed the changes in Ca 2+ transient by the non-genomic effects of aldosterone. It was demonstrated that aldosterone increased L-type Ca 2+ currents as the genomic effect but did not change it within 24 hours [17] . We and another report also showed no immediate change in the profile of twitch Ca 2+ transients in adult cardiac myocytes [26, 27] . Only one report exhibited a nifedipine-sensitive rapid increase in [Ca 2+ ] i in aldosterone-treated neonatal rat cardiac myocytes [24] . fluxes are linked to Na + -dependent Mg 2+ exchange activity, but the detailed molecular mechanisms that regulate these fluxes are still unknown [37] . It has been reported that hyperaldosteronism is associated with Mg 2+ loss in urine. Although there is no study examining the effect of aldosterone on Mg 2+ regulation in the heart, the changes in Mg 2+ status may influence the intracellular Ca 2+ regulation and cellular function.
(c) H +
The activation of Na + /H + exchange causes intracellular alkalinization because of H + extrusion. In fact, several reports have shown an aldosterone-induced rapid increase in pH i in a variety of tissues including the heart [26, 30, 38, 39] . The involvement of Na + /H + exchange was judged by the ability of amiloride derivatives to abolish the response. The increase in cytosolic pH i has important meaning because it causes not only positive inotropy (due to the leftward shift of pCa-ATPase curve of myofilaments), but also cardiac hypertrophy and remodeling as discussed below.
PHYSIOLOGICAL AND PATHO-PHYSIOLO-GICAL IMPLICATION OF NON-GENOMIC EFFE-CTS OF ALDOSTERONE (a) Cell Volume
Aldosterone has been recognized as a key regulator of fluid and electrolyte balance in many organs including the kidney. The aldosterone-induced rapid increase in cell vol- ume was reported in human mononuclear leukocytes and also in neonatal rat cardiac myocytes [30, 40] .
A recent report demonstrated that an acute exposure to elevated [Na + ] o caused rapid shrinkage of cardiac myocytes as a result of fluid loss, and aldosterone strongly suppressed it by increasing Na + entry into cardiac myocytes [30] . Thus, the principal effect of aldosterone is to maintain Na + homeostasis and to protect myocytes from osmotic stress. As shown in Fig. (1C) , we also found that aldosterone increased cell volume in adult rat ventricular myocytes [27, 41] . Since the aldosterone-induced increase in cell volume was blocked by an amiloride derivative or bumetanide (Fig. 1D) , the activation of Na + influxes was associated with the increase in cell volume [27, 42] .
(b) Contractility
Aldosterone was initially found to decrease cardiac output within 5 min, while peripheral vascular resistance and blood pressure increased [43] . More recently, aldosterone induced a negative inotropic response in human myocardial trabeculae [44] . On the other hand, in Langendorff-perfused and working rat hearts, aldosterone increased left ventricular developed pressure immediately [45, 46] . Spironolactone and eplerenone did not block these positive and negative inotropic effects. Therefore, in vivo evidence of the nongenomic effect of aldosterone on cardiac contractility has not yet been confirmed, since the changes in coronary flow and peripheral vascular resistance also occurred.
As mentioned above, aldosterone did not change Ca 2+ transients but increased pH i . The non-genomic effect of aldosterone appears to cause positive inotropy due to the leftward shift of the pCa-ATPase curve in myofilaments. In our previous study, however, the perfusion of aldosterone did not alter cell shortening in isolated rat myocytes, developed tension in rat papillary muscles, or left ventricular developed pressure in Langendorff-perfused rat hearts [27] . There seems to be species difference in contractile response to aldosterone, presumably due to the difference in response of pH i . Actually, we found that aldosterone increased pH i in guinea pig ventricular myocytes but did not in rats (personal data).
(c) Cardiac Hypertrophy, Fibrosis, and Remodeling
Basic and clinical studies have shown that aldosteroneinduced cardiac hypertrophy, fibrosis and remodeling are suppressed by MR antagonists, suggesting the genomic effects of aldosterone [3, 4, 47, 48] . However, as mentioned above, the non-genomic effects of aldosterone involve the modulation of various membrane proteins that are associated with downstream hypertrophic signals (Fig. 2) . In patients with hypertension or heart failure, local aldosterone levels are often elevated, and the aldosterone induces local expression of angiotensin-converting enzyme, creating a vicious cycle involving the renin-angiotensin-aldosterone system. Thus, the non-genomic effects of aldosterone, in concert with genomic effects, can have some patho-physiological relevance.
Actually, the aldosterone-induced activation of Na + /H + exchange, Ca 2+ overload, myocyte swelling, apoptosis, and the increase in matrix metalloproteinase (MMP) activity have been reported to contribute to cardiac hypertrophy and remodeling [24, 30, 49, 50] . Second messenger pathways that link these patho-physiological effects of aldosterone include PKC (especially its Ca 2+ -independent isoform, PKC ), mitogen/ extracellular signal-regulated kinase (MEK), extracellular signal-regulated kinase 1/2 (ERK 1/2), and the generation of reactive oxygen species (ROS) [23, 24, 49] . It is reported that aldosterone rapidly increased generation of ROS by activating NADPH oxidase [49] . The increase in ROS generation can relate to myocyte damage, inflammation, and activation of MMP.
CONCLUSIONS
Aldosterone exerts several non-genomic effects on cellular ionic regulation and function in the heart (as well as in other tissues). The various non-genomic effects of aldosterone have been described during the past decades, but the identification, characterization, and cloning of the membrane receptor for them remain the major goals. The second messengers and the interaction with MR-dependent genomic actions also remain to be elucidated. The physiological and pathophysiological relevance of non-genomic effects of aldosterone should be further characterized, and the development of novel specific antagonists may yield therapeutic benefits for a variety of cardiovascular diseases.
